BIOVENTUS INC. (BVS)

Every figure this model derived for BVS, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-27.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 2,587,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-27
cash 29,457,000 CashAndCashEquivalentsAtCarryingValue 2026-06-27
current assets 257,527,000 AssetsCurrent 2026-06-27
current liabilities 152,451,000 LiabilitiesCurrent 2026-06-27
equity 228,306,000 StockholdersEquity 2026-06-27
interest expense 27,043,000 InterestPaid 2025-12-31
ocf 96,873,000 NetCashProvidedByUsedInOperatingActivities 2026-06-27
revenue 581,848,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-27
sbc 14,921,000 ShareBasedCompensation 2026-06-27

The ratios

The figures themselves rather than their scores — what somebody looking up BVS on one particular measure came for.

RatioValue
cash operating margin20.36
current ratio1.7
current ratio reported1.69
deferred revenue growth-43.12
dilution pct6.77
ebit yoy68.51
fcf margin16.2
growth cv1.01
interest cover2.16
net debt ebitda2.2
operating margin10.02
owner earnings margin13.64
revenue growth3.14
revenue growth per share-3.4
roic10.09
rule of 4013.16
sbc pct revenue2.56

What to be careful about

What this model itself distrusts about BVS's figures. Written by the derivation as it ran, not added afterwards.